WHO ICTRP trial
Melatonin in Intensive Therapy Unit (ITU) patients
ISRCTN23173759 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN23173759 |
|---|---|
| Public title | Melatonin in Intensive Therapy Unit (ITU) patients |
| Primary sponsor | Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Nervous System Diseases: Sleep disorders Nervous System Diseases Sleep disorders |
| Interventions | Randomised controlled trial in which melatonin will be given to patients who have ceased to be sedated for their clinical care on ITU, and their physiological and psychological recovery will be recorded. Standard scoring systems are… |
| Registration date | Dec 9, 2003 |
| Target size | 0 |
| Secondary IDs | N0227109607 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: